Literature DB >> 18310914

Modifications of aliphatic side chain of 20(S)-ginsenoside RG3 cause an enhancement or loss of brain Na+ channel current inhibitions.

Jun-Ho Lee1, Sun-Hye Choi, Byung-Hwan Lee, In-Soo Yoon, Tae-Jun Shin, Mi Kyung Pyo, Sang-Mok Lee, Hyewhon Rhim, Myung Hwan Park, Tae Yoon Park, Seung-Yeol Nah.   

Abstract

A line of evidence has shown that ginsenoside Rg3 (Rg3) could be one of bioactive ligands in brain Na+ channel regulations. Rg3 exists as stereoisomer of 20(R)- or 20(S)-form. Rg3 consists of three different parts; steroid- like backbone structure, carbohydrate portion, and aliphatic side chain [-CH2CH2CH=C(CH3)2], which is coupled to the carbon-20 of backbone structure. In the previous report, we demonstrated that 20(S)- but not 20(R)-Rg3 and carbohydrate portion of Rg3 play important roles in rat brain NaV1.2 channel regulations. However, little is known about the role of aliphatic side chain coupled to the carbon-20 in brain Na+ channel regulations. In the present study, we prepared Rg3 derivatives by modifying the aliphatic side chain of Rg3, remaining with backbone structure and carbohydrate portion intact, and examined the effects of Rg3 derivatives on Na+ channel activity. We found that reduction of double bond in aliphatic side chain of Rg3 exhibited agonistic actions in Na+ channel current inhibitions by shifting concentration-response curve to leftward by three-fold, whereas deletion, hydroxylation, or oxygenation of aliphatic side chain caused an attenuation or loss of Na+ channel current inhibitions. These results provide evidences that the aliphatic side chain of Rg3 is also involved in Na+ channel regulations and further show a possibility that the aliphatic side chain of Rg3 could be the target of chemical modifications for abolishment or potentiation of Rg3 actions in Na+ channel regulations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310914     DOI: 10.1248/bpb.31.480

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

Review 1.  Ginseng compounds: an update on their molecular mechanisms and medical applications.

Authors:  Jian-Ming Lü; Qizhi Yao; Changyi Chen
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

Review 2.  Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin.

Authors:  Dong-soon Im; Seung-yeol Nah
Journal:  Acta Pharmacol Sin       Date:  2013-10-14       Impact factor: 6.150

Review 3.  Ginseng ginsenoside pharmacology in the nervous system: involvement in the regulation of ion channels and receptors.

Authors:  Seung-Yeol Nah
Journal:  Front Physiol       Date:  2014-03-19       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.